Almirall Announces CFO Transition Plan and Appoints Jon U. Garay Alonso as CFO to Succeed Mike McClellan in August 2025
Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced the appointment of Jon U. Garay Alonso as Chief Financial Officer and member of the company’s Management Board as of August 2025, succeeding Mike McClellan, who will leave the company in September 2025, after nearly six successful years as CFO.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250305566567/en/
Almirall HQ in Barcelona (Photo: Business Wire)
This planned transition is focused on maintaining business continuity and enabling the organization to keep and further build its strong trajectory towards achieving its ambition as European leader in medical dermatology.
Jon U. Garay Alonso is currently CFO at Camurus, a science-led, global pharmaceutical company focused on developing and commercializing innovative medicines with the potential to significantly improve treatment for patients with severe and chronic diseases within Central Nervous System (CNS) diseases, rare diseases, endocrine disorders, oncology and supportive care. Jon previously held positions with increasing seniority at Baxter, Gambro, Convatec, and Bristol Myers Squibb after having worked in different industry sectors before. Jon has bachelor’s and master’s degrees in business administration and has continued his professional education throughout his career. Jon will relocate from Lund, Sweden to Barcelona and report to Carlos Gallardo, Almirall Chairman and CEO.
"We are delighted to welcome Jon as CFO and member of Almirall’s management board. I am convinced that his expertise in the pharma sector and in finance and business will be important contributors to the further growth of our company, building on the work done by Mike and the Management Board in recent years. I want to thank Mike for his work as CFO of Almirall – he has played a pivotal role in the company’s development and recent growth. He leaves Almirall at a time of strength – as we have exceeded our 2024 guidance and are entering an era of sustained double-digit growth and margin expansion. As Mike is transitioning his role to Jon, we continue to be very confident in our strategy, commercial success, and our R&D capabilities which are the foundation for achieving our business ambition and leadership in medical dermatology.”
Carlos Gallardo, Almirall Chairman and CEO
About Almirall
Almirall is a global pharmaceutical company dedicated to medical dermatology. We closely collaborate with leading scientists, healthcare professionals, and patients to deliver our purpose: to transform the patients' world by helping them realize their hopes and dreams for a healthy life. We are at the forefront of science to deliver ground-breaking, differentiated medical dermatology innovations that address patients´ needs.
Almirall, founded in 1944 and headquartered in Barcelona, is publicly traded on the Spanish Stock Exchange (ticker: ALM, total revenue in 2024: €990 MM, over 2000 employees globally). Almirall products help to improve the lives of patients every day and are available in over 100 countries.
For more information, please visit https://www.almirall.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250305566567/en/
Contacts
Corporate Communications
corporate.communication@almirall.com
Phone: (+34) 93 291 35 08
Investor Relations
investors@almirall.com
Phone: (+34) 93 291 30 87
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kinaxis and Ottawa Senators Renew Partnership, Uniting National Capital Region26.6.2025 21:32:00 EEST | Press release
Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, is proud to announce a renewed three-year partnership with the Ottawa Senators and their AHL affiliate, the Belleville Senators. This collaboration is designed to amplify Kinaxis’ brand visibility, deepen community roots, and create unforgettable experiences for customers, prospects, and employees. As two proud Ottawa-based organizations, Kinaxis and the Senators will come together again to celebrate local talent, foster youth development, and drive meaningful community engagement. The partnership will also spotlight the Kinaxis brand across high-visibility platforms—including center ice at Canadian Tire Centre, LED rings, and digital dashboards during home and away games—ensuring a powerful presence throughout the NHL season. “At Kinaxis, we believe in the power of community and the importance of showing up where it matters most,” said Megan Paterson, chief operating officer at Kinaxis. “This partnership is
CB Insights Unveils Industry's First AI Agent Workforce for M&A, Partnerships, Competitive Intelligence, Deal Sourcing, GTM, and More26.6.2025 19:49:00 EEST | Press release
CB Insights, the leading provider of predictive market intelligence, today announced the launch of its Team of Agents – the industry's first comprehensive AI agent workforce designed specifically to enable business leaders with always-on market intelligence for strategic decision-making. CB Insights’ growing team of agents starts with 11 specialized agents that work continuously to uncover insights, translate proprietary data into action, and accelerate smart decisions by providing the external intelligence layer that enterprises need to compete effectively across business development, investments, partnerships, GTM, and competitive intelligence. While generic AI assistants struggle with business context and lack reliable external data, CB Insights' Team of Agents delivers validated intelligence and data science on over 10 million companies and 1,500 tech markets through purpose-built specialists that understand the nuanced requirements of strategic business functions. Enterprise clien
Pure Lithium and CEO Emilie Bodoin Recognized for Innovations at Reuters Global Energy Transition Awards26.6.2025 19:27:00 EEST | Press release
Pure Lithium Corporation, a disruptive vertically integrated lithium metal battery technology company, is pleased to announce that it has won the 2025 Reuters Global Energy Transition award for R&D Achievement. The award, presented at a June 24th ceremony in New York, recognizes research and development projects that promote a science-oriented energy transition while yielding promising potential and achievement. Pure Lithium has developed lithium metal batteries with double the energy density of lithium-ion cells and an industry-leading cycle life. By prioritizing research and development, the company achieved step-change advancements in battery technology and has built a strong portfolio of 119 patents and applications. “We’re thrilled to be selected for this prestigious award, which recognizes the hard work, dedication and creativity of our world-class team,” said Pure Lithium Founder and CEO Emilie Bodoin. “We know that commercializing a new chemistry requires a delicate balance of
Ant Group Launches AI Healthcare App AQ Amid Push into Healthcare Sector26.6.2025 17:41:00 EEST | Press release
Ant Group today launched its AI healthcare app, AQ, to accelerate the company’s entry into the healthcare sector. The app helps users manage their daily healthcare needs with over 100 AI-powered services, including doctor recommendations, medical report analysis, and personalized medical advice. It also connects users to digital services from over 5,000 hospitals and nearly 1 million doctors across China. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250626728870/en/ Ant Group launched the AI healthcare app AQ to accelerate its entry into the healthcare sector By around 2035, over 400 million people, or more than 30% of China’s population, will be aged 60 or older, according to projections from China’s National Health Commission. This demographic shift is expected to significantly increase healthcare demand in the country. “Ant Group hopes that through AQ, it can provide everyone with a trusted healthcare manager, advancing
Wasabi Technologies Becomes Official Cloud Storage Partner and Front-of-Jersey Sponsor of USA Rugby26.6.2025 17:00:00 EEST | Press release
Wasabi Technologies, the hot cloud storage company, today announced it has strengthened its sports sponsorship program as the Official Cloud Storage Partner of USA Rugby. This milestone partnership unites two organizations committed to rapid growth, excellence, and technology innovation. Wasabi is purpose-built for media-rich industries like sports and entertainment and offers simple, fast, and predictable cloud storage for organizations with growing content archives. USA Rugby now stands alongside Wasabi’s compelling sponsorship portfolio of teams unlocking the power of their data, including iconic organizations, like the Boston Red Sox and Liverpool Football Club. “With digital transformation being top of mind for all sports organizations, we can’t think of a better partner than Wasabi to innovate alongside,” said USA Rugby CEO, Bill Goren. “Wasabi has established itself as a true industry leader, and we are eager to work with them to mutually drive growth both on and off the rugby p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom